2-(4-phenoxyphenyl)-7-(1-(3-(4-(3-carbamoyl-2-(4-phenoxyphenyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-7-yl)piperidin-1-yl)-3-oxopropyl)piperidin-4-yl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide
Zanubrutinib Amide Impurity is listed by Simson Pharma as a impurity standards for laboratory research, analytical development and quality-control workflows.
Suitability is method- and purpose-specific. Before use, verify the product name, catalogue number, chemical identifiers, storage requirements and the information reported in the current product or batch documentation. Your laboratory remains responsible for method qualification or validation.
Zanubrutinib Amide Impurity for method validation Zanubrutinib Amide Impurity reference standard Zanubrutinib Amide Impurity for ANDA filing Zanubrutinib Amide Impurity for forced degradation studies Zanubrutinib Amide Impurity identification standard Zanubrutinib Amide Impurity for DMF filing Zanubrutinib Amide Impurity HPLC standard Zanubrutinib Amide Impurity supplier Zanubrutinib Amide Impurity manufacturer Zanubrutinib Amide Impurity distributor
